Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

16 oct. 2020 08h30 HE | Source: Cybin Corp.

Psychedelics Experiencing Renaissance, Offer Tremendous Treatment Potential

NEW YORK, Oct. 16, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio -- Cybin Corp. announces the availability of a broadcast titled, “Multi-Billion-Dollar Market Forecast in Psychedelic Therapeutics.” ...
15 oct. 2020 08h30 HE | Source: Cybin Corp.

Psychedelic Drugs Offering New Hope for Treatment of Debilitating Disorders

NEW YORK, Oct. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — Cybin Corp. today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ brands in the...
15 sept. 2020 08h30 HE | Source: Cybin Corp.

Cybin Corp. CEO Discusses Ongoing Efforts to Develop One of the First Commercially Approved Psychedelic Medications for Mental Health

NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio — Cybin Corp. today announces that its chief executive officer, Doug Drysdale, is featured in an exclusive audio interview with...